TECTA (Alpha-tectorin) variants and mutations
TECTA (also known as Alpha-tectorin) is a human protein-coding gene encoding an alpha-tectorin protein. Its extracellular matrix organizes the tectorial membrane that mechanically couples sound-induced motion to cochlear hair cells. Dominant or recessive pathogenic variants cause nonsyndromic hearing loss, with characteristic frequency patterns depending on the affected region. This analysis covers 3,257 TECTA variants and mutations. Of these, 68% have computational variant effect predictions. Disease context includes autosomal dominant nonsyndromic hearing loss, hearing loss, autosomal recessive, and nonsyndromic genetic hearing loss. Example TECTA variants include M1?, N2K, and Y3*.
Variant analysis overview
- Gene: TECTA
- Protein: Alpha-tectorin
- UniProt accession: O75443
- Organism: Homo sapiens
- Variants analyzed: 3257
- Variant scope: all variants
- Completed: 2026-08-18
Variant and mutation evidence
- Variant composition: 3,010 unspecified-consequence records; 112 missense variants; 106 synonymous variants; 18 frameshift variants; 6 stop-gained variants; 1 in-frame deletions; 2 splice-region variants; 1 in-frame insertions; 1 substitution
- Prediction scores: 2,199 variants have prediction scores (68% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: autosomal dominant nonsyndromic hearing loss, hearing loss, autosomal recessive, nonsyndromic genetic hearing loss, hearing loss disorder, deafness, Rare genetic deafness, Sensorineural hearing impairment, Non-syndromic genetic deafness, hereditary disease, Vertigo, Hearing impairment, Meniere disease.
Protein structure and variant hotspots
- Protein features: 10 domains; 30 post-translational modification sites.
- Structural context: 1,994 variants have structural context.
- PTM context: 48 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, AlphaFold DB, gnomAD constraint, Open Targets, ClinGen, MaveDB, LitVar.
Notable TECTA variants
Examples include M1?, N2K, Y3*, Y3D, Y3N, S5L, S5S, R8K. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- M1?, NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- N2K (p.Asn2Lys), cosmic curated COSV50796
- Y3* (p.Tyr3Ter), Ensembl rs2135046485
- Y3D (p.Tyr3Asp), NCI-TCGA Cosmic COSV5075, cosmic curated COSV50750, Variant assessed as somatic; moderate impact.
- Y3N (p.Tyr3Asn), gnomAD 11-121102672-T-A, REVEL 0.17, CADD 23.40
- S5L (p.Ser5Leu), cosmic curated COSV10506
- S5S (p.Ser5Ser), rs558472378, gnomAD 11-121102680-A-G, CADD 10.90
- R8K (p.Arg8Lys), cosmic curated COSV50688
- R8T (p.Arg8Thr), NCI-TCGA Cosmic COSV5068, Variant assessed as somatic; moderate impact.
- R8R (p.Arg8Arg), rs1321461882, gnomAD 11-121102687-A-C, CADD 12.60
- I9F (p.Ile9Phe), TOPMed rs1946356927, REVEL 0.08, MetaLR 0.08
- I9M (p.Ile9Met), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- I9N (p.Ile9Asn), Ensembl rs1946356963
- W10R (p.Trp10Arg), gnomAD rs1946357001, REVEL 0.22, MetaLR 0.08
- W10S (p.Trp10Ser), rs1591433475, ClinGen CA383019381, ClinVar RCV001002760, Ensembl rs1591433475, REVEL 0.19, MetaLR 0.09, Likely benign, Autosomal dominant nonsyndromic hearing loss 12
- W10C (p.Trp10Cys), gnomAD 11-121102695-G-C, REVEL 0.13, CADD 24.20
- V11I (p.Val11Ile), cosmic curated COSV50696, REVEL 0.07, MetaLR 0.06
- V11V (p.Val11Val), rs140393508, gnomAD 11-121102698-C-A, CADD 8.48
- S12A (p.Ser12Ala), TOPMed rs1172967669, gnomAD rs1172967669, REVEL 0.09, MetaLR 0.05
- S12F (p.Ser12Phe), gnomAD 11-121102700-C-T, REVEL 0.10, CADD 23.00
- F13V (p.Phe13Val), TOPMed rs1367039060, gnomAD rs1367039060
- F13L (p.Phe13Leu), gnomAD 11-121102704-C-A, REVEL 0.09, CADD 17.60
- F15S (p.Phe15Ser), Ensembl rs1946357161, REVEL 0.14, MetaLR 0.04
- F15V (p.Phe15Val), NCI-TCGA Cosmic COSV5069, cosmic curated COSV50694, Variant assessed as somatic; moderate impact.
- F15L (p.Phe15Leu), gnomAD 11-121102708-T-C, REVEL 0.11, CADD 22.10
- F15F (p.Phe15Phe), rs756460108, gnomAD 11-121102710-C-T, CADD 12.90
- A16P (p.Ala16Pro), ESP rs149919658, ExAC rs149919658, TOPMed rs149919658, gnomAD rs149919658, REVEL 0.22, MetaLR 0.07, Uncertain significance
- A16T (p.Ala16Thr), ESP rs149919658, ExAC rs149919658, TOPMed rs149919658, gnomAD rs149919658, REVEL 0.05, MetaLR 0.05, Uncertain significance, Inborn genetic diseases
- A16V (p.Ala16Val), rs2135046540, ClinGen CA383019463, ClinVar RCV001769048, Ensembl rs2135046540, AlphaMissense 0.10, MetaLR 0.05, Uncertain significance, not provided
- A16A (p.Ala16Ala), gnomAD 11-121102713-A-G, CADD 6.48
- L17V (p.Leu17Val), gnomAD 11-121102714-C-G, REVEL 0.05, CADD 18.00
- L17F (p.Leu17Phe), gnomAD 11-121102714-C-T, REVEL 0.06, CADD 19.80
- V18L (p.Val18Leu), cosmic curated COSV50712, REVEL 0.04, MetaLR 0.05
- V18C (p.Val18Cys), rs1365821101, gnomAD 11-121102714-C-CT, CADD 32.00
- Q19R (p.Gln19Arg), rs35507522, ClinGen CA136067, ClinVar RCV000038504, ClinVar RCV000276184, REVEL 0.07, MetaLR 0.00, Benign/Likely benign, not specified; not provided; Autosomal recessive nonsyndromic hearing loss 21
- Q19L (p.Gln19Leu), gnomAD 11-121102721-A-T, REVEL 0.06, CADD 7.96
- Q19Q (p.Gln19Gln), rs1367675477, gnomAD 11-121102722-G-A, CADD 5.71
- H20R (p.His20Arg), gnomAD 11-121102724-A-G, REVEL 0.11, CADD 16.90
- H20Q (p.His20Gln), gnomAD 11-121102725-C-A, REVEL 0.03, CADD 8.85
- Q21R (p.Gln21Arg), gnomAD rs1339719437
- A22S (p.Ala22Ser), gnomAD 11-121102726-C-CA, CADD 27.90
- A22T (p.Ala22Thr), gnomAD 11-121102729-G-A, REVEL 0.12, CADD 32.00
- Q23K (p.Gln23Lys), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- P24P (p.Pro24Pro), gnomAD 11-121105838-C-T, CADD 14.10
- R25T (p.Arg25Thr), rs559306344, ClinGen CA6326419, ClinVar RCV003261633, 1000Genomes rs559306344, REVEL 0.13, MetaLR 0.08, Uncertain significance, Inborn genetic diseases
- E26G (p.Glu26Gly), TOPMed rs1946384981
- E26* (p.Glu26Ter), gnomAD 11-121105842-G-T, CADD 43.00
- E26E (p.Glu26Glu), rs369393738, gnomAD 11-121105844-G-A, CADD 8.03
- L27F (p.Leu27Phe), TOPMed rs1041298366, gnomAD rs1041298366, REVEL 0.05, MetaLR 0.06
- L27I (p.Leu27Ile), TOPMed rs1041298366, gnomAD rs1041298366, REVEL 0.06, MetaLR 0.03
- L27P (p.Leu27Pro), rs373248083, ClinGen CA6326420, ClinVar RCV000290359, ClinVar RCV000328929, REVEL 0.18, MetaLR 0.06, Uncertain significance, not provided; Autosomal recessive nonsyndromic hearing loss 21; Autosomal domina
- L27R (p.Leu27Arg), gnomAD 11-121105846-T-G, REVEL 0.15, CADD 24.50
- L27L (p.Leu27Leu), gnomAD 11-121105847-C-T, CADD 11.40
- M28I (p.Met28Ile), rs2496886043, ClinGen CA383019905, ClinVar RCV003364871, ClinVar RCV004697287, REVEL 0.13, MetaLR 0.08, Uncertain significance, not provided; Inborn genetic diseases
- M28T (p.Met28Thr), Ensembl rs1946385131
- M28V (p.Met28Val), gnomAD rs1384281678, REVEL 0.14, MetaLR 0.07
- M28L (p.Met28Leu), gnomAD 11-121105848-A-C, REVEL 0.14, CADD 17.50
- Y29H (p.Tyr29His), gnomAD 11-121105851-T-C, REVEL 0.52, CADD 28.00
- Y29C (p.Tyr29Cys), gnomAD 11-121105852-A-G, REVEL 0.56, CADD 29.60
- Y29Y (p.Tyr29Tyr), gnomAD 11-121105853-T-C, CADD 7.58
- P30S (p.Pro30Ser), NCI-TCGA Cosmic COSV5073, cosmic curated COSV50731, Variant assessed as somatic; moderate impact.
- P30A (p.Pro30Ala), gnomAD 11-121105854-C-G, REVEL 0.49, CADD 24.70
- P30P (p.Pro30Pro), rs577470721, gnomAD 11-121105856-A-T, CADD 7.12
- F31C (p.Phe31Cys), TOPMed rs1419140766, gnomAD rs1419140766, REVEL 0.31, MetaLR 0.25
- F31S (p.Phe31Ser), TOPMed rs1419140766, gnomAD rs1419140766, REVEL 0.28, MetaLR 0.19, Uncertain significance, not provided
- W32* (p.Trp32Ter), NCI-TCGA Cosmic COSV9987, cosmic curated COSV99879, Variant assessed as somatic; high impact.
- W32L (p.Trp32Leu), cosmic curated COSV50687
- Q33* (p.Gln33Ter), ExAC rs765570531, gnomAD rs765570531, CADD 40.00
- Q33H (p.Gln33His), cosmic curated COSV10803
- Q33Q (p.Gln33Gln), gnomAD 11-121105865-G-A, CADD 10.10
- N34K (p.Asn34Lys), rs2135050168, gnomAD 11-121105867-AT-A, CADD 28.70
- D35A (p.Asp35Ala), TOPMed rs1591434716, REVEL 0.58, MetaLR 0.44
- D35N (p.Asp35Asn), cosmic curated COSV50829, REVEL 0.33, MetaLR 0.46
- D35H (p.Asp35His), gnomAD 11-121105869-G-C, REVEL 0.44, CADD 31.00
- D35D (p.Asp35Asp), gnomAD 11-121105871-C-T, CADD 10.40
- T36S (p.Thr36Ser), cosmic curated COSV99880
- K37R (p.Lys37Arg), gnomAD 11-121105876-A-G, REVEL 0.10, CADD 22.10
- T38A (p.Thr38Ala), gnomAD rs1375830657, REVEL 0.36, MetaLR 0.26
- T38I (p.Thr38Ile), rs750770599, ClinGen CA6326423, ClinVar RCV003227374, ExAC rs750770599, REVEL 0.32, MetaLR 0.24, Uncertain significance, not provided
- T38N (p.Thr38Asn), ExAC rs750770599, gnomAD rs750770599, REVEL 0.26, MetaLR 0.19, Uncertain significance
- T38T (p.Thr38Thr), gnomAD 11-121105880-C-T, CADD 9.69
- P39T (p.Pro39Thr), Ensembl rs867450967
- P39S (p.Pro39Ser), gnomAD 11-121105881-C-T, REVEL 0.22, CADD 23.80
- P39R (p.Pro39Arg), gnomAD 11-121105882-C-G, REVEL 0.23, CADD 25.90
- K40E (p.Lys40Glu), ExAC rs766694581, gnomAD rs766694581
- V41A (p.Val41Ala), rs1946385502, ClinGen CA383020082, ClinVar RCV004469465, TOPMed rs1946385502, REVEL 0.08, MetaLR 0.06, Uncertain significance, Inborn genetic diseases
- V41L (p.Val41Leu), Ensembl rs746640989, REVEL 0.10, MetaLR 0.11
- V41E (p.Val41Glu), gnomAD 11-121105888-T-A, REVEL 0.11, CADD 24.50
- D43G (p.Asp43Gly), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- G44R (p.Gly44Arg), gnomAD rs1407982133, REVEL 0.73, MetaLR 0.85
- S45N (p.Ser45Asn), cosmic curated COSV50703
- S47C (p.Ser47Cys), rs2496886199, ClinGen CA383020161, ClinVar RCV003330274, Uncertain significance, Autosomal dominant nonsyndromic hearing loss 12
- S47P (p.Ser47Pro), TOPMed rs911373313
- S47Y (p.Ser47Tyr), gnomAD 11-121105906-C-A, REVEL 0.35, CADD 23.20
- S47S (p.Ser47Ser), rs1444318259, gnomAD 11-121105907-T-C, CADD 3.71
- E48E (p.Glu48Glu), rs751702344, gnomAD 11-121105910-G-A, CADD 8.66
- I49T (p.Ile49Thr), TOPMed rs1458677810, REVEL 0.81, MetaLR 0.66, Uncertain significance, Inborn genetic diseases
- I49L (p.Ile49Leu), gnomAD 11-121105911-A-C, REVEL 0.24, CADD 25.50
- K50E (p.Lys50Glu), NCI-TCGA Cosmic COSV9987, cosmic curated COSV99878, Variant assessed as somatic; moderate impact.
- K50Q (p.Lys50Gln), gnomAD 11-121105914-A-C, REVEL 0.08, CADD 21.90
- L51L (p.Leu51Leu), rs755041065, gnomAD 11-121105917-T-C, CADD 6.02
- A52S (p.Ala52Ser), gnomAD rs1946385730, REVEL 0.13, MetaLR 0.07
- A52V (p.Ala52Val), NCI-TCGA Cosmic COSV5069, cosmic curated COSV50691, REVEL 0.24, MetaLR 0.34, Variant assessed as somatic; moderate impact.
- A52del (p.Ala52del), rs753424297, gnomAD 11-121105919-GGCC, CADD 18.10
- A52G (p.Ala52Gly), gnomAD 11-121105921-C-G, REVEL 0.25, CADD 21.90
- I53T (p.Ile53Thr), gnomAD 11-121105924-T-C, REVEL 0.21, CADD 23.20
- I53I (p.Ile53Ile), gnomAD 11-121105925-C-T, CADD 7.52
- P54A (p.Pro54Ala), rs374289159, ClinGen CA229826640, ClinVar RCV003386700, TOPMed rs374289159, AlphaMissense 0.27, MetaLR 0.48, Uncertain significance, Inborn genetic diseases
- P54S (p.Pro54Ser), TOPMed rs374289159, gnomAD rs374289159, REVEL 0.58, AlphaMissense 0.27, Uncertain significance
- P54Q (p.Pro54Gln), rs1403544978, gnomAD 11-121105924-TC-T, CADD 23.50
- P54P (p.Pro54Pro), rs1312099818, gnomAD 11-121105928-A-G, CADD 1.64
- V55I (p.Val55Ile), TOPMed rs1398748614, gnomAD rs1398748614, REVEL 0.14, MetaLR 0.17, Uncertain significance, Inborn genetic diseases
- V55F (p.Val55Phe), rs1299330274, gnomAD 11-121105927-CA-C, CADD 13.20
- V55V (p.Val55Val), gnomAD 11-121105931-T-C, CADD 3.21
- F56L (p.Phe56Leu), NCI-TCGA Cosmic COSV5073, Variant assessed as somatic; moderate impact.
- F57L (p.Phe57Leu), NCI-TCGA TCGA novel, cosmic curated COSV50789, REVEL 0.79, MetaLR 0.64, Variant assessed as somatic; moderate impact.
- F57S (p.Phe57Ser), gnomAD rs1224604977, REVEL 0.81, MetaLR 0.76
- F57F (p.Phe57Phe), rs1265575754, gnomAD 11-121105937-C-T, CADD 15.20
- F58F (p.Phe58Phe), gnomAD 11-121105940-T-C, CADD 5.18
- F58L (p.Phe58Leu), gnomAD 11-121105940-T-G, REVEL 0.71, CADD 19.60
- G59R (p.Gly59Arg), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- G59D (p.Gly59Asp), gnomAD 11-121105942-G-A, REVEL 0.34, CADD 23.50
- G59V (p.Gly59Val), gnomAD 11-121105942-G-T, REVEL 0.64, CADD 26.50
- G59G (p.Gly59Gly), rs1946386017, gnomAD 11-121105943-C-T, CADD 8.36
- V60F (p.Val60Phe), ESP rs376541939, ExAC rs376541939, gnomAD rs376541939, REVEL 0.25, MetaLR 0.29
- V60I (p.Val60Ile), cosmic curated COSV50695, ESP rs376541939, ExAC rs376541939, gnomAD rs376541939, REVEL 0.16, MetaLR 0.32, Uncertain significance, Inborn genetic diseases
- V60L (p.Val60Leu), ESP rs376541939, ExAC rs376541939, gnomAD rs376541939, REVEL 0.14, MetaLR 0.24
- P61L (p.Pro61Leu), NCI-TCGA Cosmic COSV5068, cosmic curated COSV50688, Variant assessed as somatic; moderate impact.
- P61S (p.Pro61Ser), TOPMed rs1041510767, gnomAD rs1041510767, REVEL 0.38, MetaLR 0.43
- P61T (p.Pro61Thr), TOPMed rs1041510767, gnomAD rs1041510767, REVEL 0.46, MetaLR 0.37, Uncertain significance, not provided
- P61A (p.Pro61Ala), gnomAD 11-121105947-C-G, REVEL 0.46, CADD 23.10
- Y62C (p.Tyr62Cys), NCI-TCGA Cosmic COSV5068, cosmic curated COSV50687, Variant assessed as somatic; moderate impact.
- Y62Y (p.Tyr62Tyr), rs2135050272, gnomAD 11-121105952-C-T, CADD 9.22
- R63C (p.Arg63Cys), rs876658015, ClinGen CA10576832, cosmic curated COSV50750, ClinVar RCV000215968, REVEL 0.52, MetaLR 0.53, Uncertain significance, not specified; not provided; Autosomal dominant nonsyndromic hearing loss 12
- R63H (p.Arg63His), cosmic curated COSV10803, ExAC rs757192942, TOPMed rs757192942, gnomAD rs757192942, REVEL 0.43, MetaLR 0.35, Uncertain significance, Inborn genetic diseases; not provided
- R63L (p.Arg63Leu), rs757192942, ExAC rs757192942, TOPMed rs757192942, gnomAD rs757192942, REVEL 0.57, MetaLR 0.52, Variant assessed as somatic; moderate impact.
- R63S (p.Arg63Ser), Ensembl rs876658015, Uncertain significance
- T64A (p.Thr64Ala), gnomAD rs1946386251, REVEL 0.30, MetaLR 0.33
- T64T (p.Thr64Thr), rs778610400, gnomAD 11-121105958-T-C, CADD 1.06
- V65M (p.Val65Met), gnomAD 11-121105956-ACTG, CADD 33.00
- V65I (p.Val65Ile), gnomAD 11-121105959-G-A, REVEL 0.14, CADD 14.20
- Y66C (p.Tyr66Cys), rs745665835, ExAC rs745665835, TOPMed rs745665835, gnomAD rs745665835, REVEL 0.76, MetaLR 0.62, Variant assessed as somatic; moderate impact.
- Y66H (p.Tyr66His), TOPMed rs1565515727, REVEL 0.76, MetaLR 0.63, Uncertain significance, Inborn genetic diseases
- V67I (p.Val67Ile), TOPMed rs1946420757
- V67L (p.Val67Leu), rs1946420757, ClinGen CA383020407, ClinVar RCV003548582, AlphaMissense 0.15, MetaLR 0.47, Uncertain significance, not provided
- N68D (p.Asn68Asp), TOPMed rs1946420783, REVEL 0.73, MetaLR 0.75
- N68S (p.Asn68Ser), ExAC rs778855778, TOPMed rs778855778, gnomAD rs778855778, REVEL 0.67, MetaLR 0.70, Uncertain significance, Inborn genetic diseases
- N68T (p.Asn68Thr), ExAC rs778855778, TOPMed rs778855778, gnomAD rs778855778, Uncertain significance
- N69S (p.Asn69Ser), ExAC rs758152552, gnomAD rs758152552, REVEL 0.56, MetaLR 0.68
- N70T (p.Asn70Thr), NCI-TCGA Cosmic COSV9987, cosmic curated COSV99878, Variant assessed as somatic; moderate impact.
- N70K (p.Asn70Lys), gnomAD 11-121109219-C-CA, CADD 33.00
- N70N (p.Asn70Asn), rs779707919, gnomAD 11-121109222-C-T, CADD 0.16
- G71A (p.Gly71Ala), gnomAD rs1226982432
- G71E (p.Gly71Glu), gnomAD rs1226982432, REVEL 0.83, MetaLR 0.77
- G71R (p.Gly71Arg), rs1364447010, TOPMed rs1364447010, gnomAD rs1364447010, REVEL 0.84, MetaLR 0.81, Uncertain significance, Autosomal recessive nonsyndromic hearing loss 21
- V72S (p.Val72Ser), rs1565516684, gnomAD 11-121109222-C-CG, CADD 34.00
- V72V (p.Val72Val), gnomAD 11-121109228-T-G, CADD 4.25
- S74F (p.Ser74Phe), NCI-TCGA Cosmic COSV5076, cosmic curated COSV50767, Variant assessed as somatic; moderate impact.
- S74P (p.Ser74Pro), ExAC rs746713225, gnomAD rs746713225, REVEL 0.80, MetaLR 0.73
- S74A (p.Ser74Ala), gnomAD 11-121109232-T-G, REVEL 0.64, CADD 25.90
- F75L (p.Phe75Leu), NCI-TCGA Cosmic COSV9988, cosmic curated COSV99880, Variant assessed as somatic; moderate impact.
- N76S (p.Asn76Ser), rs768267586, ClinGen CA6326457, ClinVar RCV003370362, ExAC rs768267586, REVEL 0.35, MetaLR 0.37, Uncertain significance, Inborn genetic diseases
- N76Y (p.Asn76Tyr), cosmic curated COSV10957
- V77A (p.Val77Ala), rs2135054815, ClinGen CA383020477, ClinVar RCV001978544, Ensembl rs2135054815, AlphaMissense 0.41, MetaLR 0.19, Uncertain significance, not provided
- V77L (p.Val77Leu), rs1045493065, ClinGen CA229829055, ClinVar RCV001581639, TOPMed rs1045493065, REVEL 0.26, MetaLR 0.31, Uncertain significance, not provided
- V77M (p.Val77Met), TOPMed rs1045493065, gnomAD rs1045493065, Uncertain significance
- V77V (p.Val77Val), rs1292190337, gnomAD 11-121109243-G-A, CADD 8.81
- L78V (p.Leu78Val), rs2496891356, ClinGen CA383020480, ClinVar RCV003319875, REVEL 0.16, MetaLR 0.26, Uncertain significance, not provided
- L78P (p.Leu78Pro), gnomAD 11-121109245-T-C, REVEL 0.19, CADD 22.60
- L78L (p.Leu78Leu), gnomAD 11-121109246-A-G, CADD 0.66
- V79L (p.Val79Leu), TOPMed rs1222538532, gnomAD rs1222538532
- V79M (p.Val79Met), TOPMed rs1222538532, gnomAD rs1222538532, REVEL 0.39, MetaLR 0.47
- V79V (p.Val79Val), rs1293376139, gnomAD 11-121109249-G-A, CADD 6.62
- S80C (p.Ser80Cys), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- S80S (p.Ser80Ser), rs142064539, gnomAD 11-121109252-C-T, CADD 9.51
- S80R (p.Ser80Arg), gnomAD 11-121109252-C-A, REVEL 0.23, CADD 23.40
- Q81R (p.Gln81Arg), NCI-TCGA Cosmic COSV9987, cosmic curated COSV99878, Variant assessed as somatic; moderate impact.
- Q81* (p.Gln81Ter), gnomAD 11-121109253-C-T, CADD 39.00
- T83M (p.Thr83Met), rs145898158, ClinGen CA6326458, cosmic curated COSV50797, ClinVar RCV001004808, REVEL 0.29, MetaLR 0.35, Conflicting interpretations, Autosomal recessive nonsyndromic hearing loss 21; Autosomal dominant nonsyndromi
- T83P (p.Thr83Pro), gnomAD 11-121109259-A-C, REVEL 0.49, CADD 26.20
Public TECTA analysis runs
- TECTA analysis run — TECTA (3,257 variants) — completed 2026-08-18